GRMN
40
3
LH
48
2
IFF
62
5
BLK
61
-2
LOW
45
2
AIV
48
4
HPE
68
-5
DRI
64
4
EL
59
-2
NEM
69
-2
HRL
38
3
ETN
61
2
COST
53
5
ALL
61
-2
NWL
57
3
CPB
37
2
DUK
59
4
KO
44
2
AN
52
2
DVN
40
-2
GRMN
40
3
LH
48
2
IFF
62
5
BLK
61
-2
LOW
45
2
AIV
48
4
HPE
68
-5
DRI
64
4
EL
59
-2
NEM
69
-2
HRL
38
3
ETN
61
2
COST
53
5
ALL
61
-2
NWL
57
3
CPB
37
2
DUK
59
4
KO
44
2
AN
52
2
DVN
40
-2
Financhill
Back

AbbVie, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59

ABBV
AbbVie, Inc.

Last Price:
$230.01
Seasonality Move:
0.29%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight selling pressure.

AbbVie, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 226.46 Buy
20-day SMA: 226.01 Buy
50-day SMA: 226.61 Buy
200-day SMA: 205.71 Buy
8-day EMA: 227.12 Buy
20-day EMA: 226.61 Buy
50-day EMA: 225.39 Buy
200-day EMA: 209.84 Buy

AbbVie, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 55.83 Buy
Chaikin Money Flow: -96 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (223.81 - 230.59) Buy
Bollinger Bands (100): (210.83 - 231.65) Buy

AbbVie, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for AbbVie, Inc. Stock

Is AbbVie, Inc. Stock a Buy?

  • AbbVie, Inc. share price is 229.89 while ABBV 8-day simple moving average is 226.46, which is a Buy signal.
  • The stock price of ABBV is 229.89 while AbbVie, Inc. 20-day SMA is 226.01, which makes it a Buy.
  • AbbVie, Inc. 50-day simple moving average is 226.61 while ABBV share price is 229.89, making it a Buy technically.
  • ABBV stock price is 229.89 and AbbVie, Inc. 200-day simple moving average is 205.71, creating a Buy signal.

ABBV Technical Analysis vs Fundamental Analysis

Buy
59
AbbVie, Inc. (ABBV) is a Buy

Is AbbVie, Inc. a Buy or a Sell?

  • AbbVie, Inc. stock is rated a Buy
    The current AbbVie, Inc. [ABBV] share price is $229.89. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.

AbbVie, Inc. Stock Info

Market Cap:
406.3B
Price in USD:
229.89
Share Volume:
1.7M

AbbVie, Inc. 52-Week Range

52-Week High:
244.81
52-Week Low:
164.39
Buy
59
AbbVie, Inc. (ABBV) is a Buy

AbbVie, Inc. Share Price Forecast

  • What is the AbbVie, Inc. stock price today?
    The AbbVie, Inc. stock price is 229.89 USD today.
  • Will ABBV stock go up or go down?
    AbbVie, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is AbbVie, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie, Inc. is not overvalued.

Is AbbVie, Inc. Stock a Buy?

  • AbbVie, Inc. share price is 229.89 while ABBV 8-day exponential moving average is 227.12, which is a Buy signal.
  • The stock price of ABBV is 229.89 while AbbVie, Inc. 20-day EMA is 226.61, which makes it a Buy.
  • AbbVie, Inc. 50-day exponential moving average is 225.39 while ABBV share price is 229.89, making it a Buy technically.
  • ABBV stock price is 229.89 and AbbVie, Inc. 200-day simple moving average is 209.84, creating a Buy signal.

Fundamental Analysis of AbbVie, Inc.

Is AbbVie, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.

Technical Analysis of AbbVie, Inc.

Should I short AbbVie, Inc. stock?

* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.